title: Is Bayesian analysis ready for use in phase III randomized clinical trials? Beware the sound of the sirens.
authors.affiliation: Department of Biostatistics, University of Alabama at Birmingham, AL 35294-0022, USA. ghoward@uab.edu
authors.forename: George
authors.initials: G
authors.lastname: Howard
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Coffey
authors.forename: Gary R
authors.initials: GR
authors.lastname: Cutter
mesh_terms: D001499:Bayes Theorem; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D003627:Data Interpretation, Statistical; D006801:Humans; D011336:Probability; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D018401:Sample Size